On September 25, 2019 Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its immune tolerance platform technology, ImmTOR, reported that Selecta’s Chief Executive Officer, Carsten Brunn, Ph.D., will present at the following upcoming investor conferences in October (Press release, Selecta Biosciences, SEP 25, 2019, View Source [SID1234539770]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: 2019 Cantor Global Healthcare Conference
Date: Wednesday, October 2, 2019
Presentation Time: 10:40 a.m. Eastern Time
Location: New York City

Event: Chardan’s 3rd Annual Genetic Medicines Conference
Date: Tuesday, October 8, 2019
Presentation Time: 10:30 a.m. Eastern Time
Location: New York City

To access copies and the live webcasts of Selecta’s presentations, please visit the Investors & Media section of the Selecta website at www.selectabio.com. Replays of the webcasts will be available on the Selecta website for 90 days following the events.